RESOunD: REbif Satisfaction On Discontinuing Oral Dimethyl Fumarate
Status:
Terminated
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
This is a Phase IV, prospective, open-label, multi-center trial to assess the treatment
satisfaction in patients with relapsing forms of Multiple Sclerosis (MS) who are currently
being treated with, but are considering discontinuing treatment with Tecfidera™.